FDA clears Stanford Medicine-spawned sepsis test, developed using machine learning, that leverages publicly available medical datasets from around the world.
The so-called ‘forever chemicals’ can stick around in the environment — and in our bodies. Scientists agree there is cause for concern. So what should we be doing to mitigate our health risks?
Health care providers must reckon with inherent race-based biases in medicine, which can reinforce false stereotypes in algorithms and lead to improper treatment recommendations or late diagnoses.
Friends and colleagues, Stanford nephrology fellows Daniel Watford and Dimitri Augustin trained alongside each other in Florida and then both moved west.
Stanford researchers found that Californians living in areas of high agricultural activity are more likely to have unexplained end-stage renal disease.
Results from a multi-center clinical trial show that a drug lowers the risk of kidney failure by a third in people with Type 2 diabetes and kidney disease.
A government program providing market-value, noncash compensation to kidney donors would benefit poor people and not be exploitative, according to a study.
A kidney disease of unknown origin is sickening many men in Sri Lanka. Stanford researcher Shuchi Anand is working to understand it and to improve care.
